FDA Approved: QALSODY — Original Application (Biogen Inc.)

View source ↗

Summary

FDA approved QALSODY (tofersen) from Biogen in an original NDA (NDA215887). It is indicated for the treatment of amyotrophic lateral sclerosis caused by SOD1 ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Qalsody (Tofersen)

Snippet

ORIG AP for QALSODY (TOFERSEN)